Literature DB >> 21533622

Fungal infection in a patient with multiple sclerosis.

D Pisa1, R Alonso, L Carrasco.   

Abstract

Multiple sclerosis (MS) is a chronic, inflammatory disease of the central nervous system, whose causes are still unknown. We have proposed that MS, as well as some ophthalmologic diseases, are associated with fungal infection. In the present study, we closely monitored a patient with MS over a three-year period. Antibodies against different Candida spp. were detected in peripheral blood serum, although the titer of these antibodies fluctuated. The presence of fungal macromolecules, such as proteins, polysaccharides, and DNA, was also tested. In several sera samples, antigens related to C. famata were evidenced by the slot-blot test using a rabbit polyclonal antibody against these species, while high levels of β-1,3 glucan were detected with the commercial Fungitell assay. Despite the variations by sample, we concluded that all fungal macromolecules, that is, proteins, polysaccharides, and DNA, were present in blood from the MS patient which was analyzed. Several fungal species were identified using polymerase chain reaction (PCR) followed by sequencing. Antibodies against Candida spp. as well as C. famata-related antigens were also detected in cerebrospinal fluid (CSF). Our findings provide support for the notion that disseminated mycosis is present in this patient.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533622     DOI: 10.1007/s10096-011-1206-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  39 in total

Review 1.  Immunity to Candida albicans: Th1, Th2 cells and beyond.

Authors:  L Romani
Journal:  Curr Opin Microbiol       Date:  1999-08       Impact factor: 7.934

Review 2.  Innate immune mechanisms for recognition and uptake of Candida species.

Authors:  Mihai G Netea; László Maródi
Journal:  Trends Immunol       Date:  2010-08-11       Impact factor: 16.687

Review 3.  Infectious causes of multiple sclerosis.

Authors:  Gavin Giovannoni; Gary R Cutter; Jan Lunemann; Roland Martin; Christian Münz; Subramaniam Sriram; Israel Steiner; Margaret R Hammerschlag; Charlotte A Gaydos
Journal:  Lancet Neurol       Date:  2006-10       Impact factor: 44.182

Review 4.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

Review 5.  [Usefulness of biological markers in the diagnosis of invasive candidiasis].

Authors:  José Pontón
Journal:  Rev Iberoam Micol       Date:  2009-05-07       Impact factor: 1.044

Review 6.  Role of the innate immune system in the pathogenesis of multiple sclerosis.

Authors:  Roopali Gandhi; Alice Laroni; Howard L Weiner
Journal:  J Neuroimmunol       Date:  2010-04-15       Impact factor: 3.478

Review 7.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 8.  Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome.

Authors:  Heiko Santelmann; John McLaren Howard
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-01       Impact factor: 2.566

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

10.  Evolution of antibody response and fungal antigens in the serum of a patient infected with Candida famata.

Authors:  Diana Pisa; Marta Ramos; Susana Molina; Patricia García; Luis Carrasco
Journal:  J Med Microbiol       Date:  2007-05       Impact factor: 2.472

View more
  10 in total

Review 1.  Infectious agents and amyotrophic lateral sclerosis: another piece of the puzzle of motor neuron degeneration.

Authors:  David Castanedo-Vazquez; Pilar Bosque-Varela; Arancha Sainz-Pelayo; Javier Riancho
Journal:  J Neurol       Date:  2018-05-29       Impact factor: 4.849

2.  Alzheimer's disease and disseminated mycoses.

Authors:  R Alonso; D Pisa; A Rábano; L Carrasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-23       Impact factor: 3.267

3.  Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.

Authors:  D Pisa; R Alonso; F J Jiménez-Jiménez; L Carrasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-16       Impact factor: 3.267

4.  Oral Colonization by Candida Species in Patients with Multiple Sclerosis.

Authors:  Eliana Tomomi Shimabukuro da Cunha; Lívia Mara Alves Figueiredo-Godoi; Diogo Haddad Santos; Rafael Paterno Castello Dias Carneiro; Guilherme Sciascia do Olival; Patrícia Pimentel de Barros; Keila Narimatsu; Charles Peter Tilbery; Juliana Campos Junqueira
Journal:  Mycopathologia       Date:  2020-08-27       Impact factor: 2.574

5.  Evidence for fungal infection in cerebrospinal fluid and brain tissue from patients with amyotrophic lateral sclerosis.

Authors:  Ruth Alonso; Diana Pisa; Ana Isabel Marina; Esperanza Morato; Alberto Rábano; Izaskun Rodal; Luis Carrasco
Journal:  Int J Biol Sci       Date:  2015-04-02       Impact factor: 6.580

6.  Experimental autoimmune encephalomyelitis development is aggravated by Candida albicans infection.

Authors:  Thais F C Fraga-Silva; Luiza A N Mimura; Camila M Marchetti; Fernanda Chiuso-Minicucci; Thais G D França; Sofia F G Zorzella-Pezavento; James Venturini; Maria S P Arruda; Alexandrina Sartori
Journal:  J Immunol Res       Date:  2015-04-19       Impact factor: 4.818

Review 7.  The Beneficial and Debilitating Effects of Environmental and Microbial Toxins, Drugs, Organic Solvents and Heavy Metals on the Onset and Progression of Multiple Sclerosis.

Authors:  Mahmood Y Hachim; Noha M Elemam; Azzam A Maghazachi
Journal:  Toxins (Basel)       Date:  2019-03-05       Impact factor: 4.546

8.  Curdlan, a Microbial β-Glucan, Has Contrasting Effects on Autoimmune and Viral Models of Multiple Sclerosis.

Authors:  Fumitaka Sato; Yumina Nakamura; Aoshi Katsuki; Sundar Khadka; Ijaz Ahmad; Seiichi Omura; Nicholas E Martinez; Ikuo Tsunoda
Journal:  Front Cell Infect Microbiol       Date:  2022-02-07       Impact factor: 5.293

9.  Systemic Infection by Non-albicans Candida Species Affects the Development of a Murine Model of Multiple Sclerosis.

Authors:  Thais Fernanda de Campos Fraga-Silva; Natália Munhoz-Alves; Luiza Ayumi Nishiyama Mimura; Larissa Ragozo Cardoso de Oliveira; Lívia Mara Alves Figueiredo-Godoi; Maíra Terra Garcia; Evelyn Silva Oliveira; Larissa Lumi Watanabe Ishikawa; Sofia Fernanda Gonçalves Zorzella-Pezavento; Vânia Luiza Deperon Bonato; Juliana Campos Junqueira; Eduardo Bagagli; Alexandrina Sartori
Journal:  J Fungi (Basel)       Date:  2022-04-10

10.  Evaluation of APR1 Gene Expression in Candida albicans Strains Isolated From Patients With Multiple Sclerosis.

Authors:  Shahla Amri Saroukolaei; Mojdeh Ghabaee; Hojjatollah Shokri; Alireza Khosravi; Alireza Badiei
Journal:  Jundishapur J Microbiol       Date:  2016-04-09       Impact factor: 0.747

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.